These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23868992)

  • 1. Japan. Tampered data cast shadow on drug trial.
    Normile D
    Science; 2013 Jul; 341(6143):223. PubMed ID: 23868992
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomedicine. Faulty drug trials tarnish Japan's clinical research.
    Normile D
    Science; 2014 Jul; 345(6192):17. PubMed ID: 24994629
    [No Abstract]   [Full Text] [Related]  

  • 4. [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct; 93(44):1836. PubMed ID: 15559910
    [No Abstract]   [Full Text] [Related]  

  • 5. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 6. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 7. The Valsartan Antihypertensive Long-Term Use Evaluation trial: a study in contrasts.
    Sica DA
    Hypertension; 2006 Sep; 48(3):362-3. PubMed ID: 16864742
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
    [No Abstract]   [Full Text] [Related]  

  • 10. [VALISH].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial rigging: again!
    Prescrire Int; 2014 Apr; 23(148):110. PubMed ID: 24860906
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination effect of calcium channel blocker and valsartan on cardiovascular event prevention in patients with high-risk hypertension: ancillary results of the KYOTO HEART Study.
    Sawada T; Yamada H; Shiraishi J; Kimura S; Matsubara H
    Clin Exp Hypertens; 2012; 34(2):153-9. PubMed ID: 22008090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Valsartan: arguments for the high dose concept].
    MMW Fortschr Med; 2006 Dec; 148(51-52):54-5. PubMed ID: 17619348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 15. The VALUE trial: a commentary.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
    MMW Fortschr Med; 2006 Sep; 148(38):17. PubMed ID: 17036956
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin receptor blockers: dose does matter.
    Sarzani R; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 Mar; 26(3):607-8; author reply 608. PubMed ID: 18300874
    [No Abstract]   [Full Text] [Related]  

  • 18. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 20. [High dose sartan plus diuretic. More power in hypertension and its sequelae].
    MMW Fortschr Med; 2003 Mar; 145(11):59. PubMed ID: 12688201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.